TLDR New treatments for hair loss are being developed using molecular biology.
This document from 18 years ago discusses investigational medications for the treatment of alopecia, including androgenetic alopecia (AGA) and chemotherapy-induced alopecia. The article explains the pathogenesis of hair growth and how androgens are the most important hormone known to regulate hair growth. Currently, there are only two treatments approved by the US FDA for the treatment of AGA: minoxidil topical solution and finasteride. The article concludes by stating that advances in molecular biology are paving the way for a very exciting era of new therapeutics for hair disorders. The document provides expert opinions on various targeted treatments for androgenetic and chemotherapy-induced alopecia, including Namindil, fluridil, PSK-3841, LGD-1331, antiandrogen ODNs, steroid sulfatase inhibitors, KF19418, and thymosin ß4.View this study on tandfonline.com →
The substance AS101 can help hair grow by slowing down hair cell aging and boosting a hair growth protein.
Finasteride potentially treats hair loss by reducing DHT production.
RU58841, a nonsteroidal anti-androgen, showed potential as a topical treatment for hair loss, increasing hair density, thickness, and length without systemic side effects in Stumptailed Macaques.
Minoxidil shortens baldness from chemotherapy by 50.2 days without significant side effects.
Finasteride treats enlarged prostate and may help with baldness, but effects on sexual function and male fetuses are unclear.
RU 58841 may treat acne, hair loss, and excessive hair growth.